View Post

New Clinical Research on Chimeric Antigen Receptor (CAR) T-Cell Therapy Presented at 60th American Society of Hematology Annual Meeting

In Clinical Trials by Barbara Jacoby

Source:    Yadira Galindo, Health Journalist The 60th American Society of Hematology (ASH) Annual Meeting, the largest international conference and exhibition in the field of hematology, is currently taking place at the San Diego Convention Center.  Dr. Peihua Lu, the Medical Executive President of the Hebei Yanda Lu Daopei Hospital, and Dr. Xian Zhang from the same institution were invited by …

View Post

9 things to know about CAR T-cell therapy

In Clinical Trials by Barbara Jacoby

By: Cynthia DeMarco From: mdanderson.org CAR T-cell therapy is a new type of cancer treatment offered at MD Anderson through clinical trials and FDA-approved standard of care cell therapy products. But what exactly is CAR T-cell therapy? And who should consider it? We spoke with Sattva Neelapu, M.D., to learn more. Here’s what he had to say. Let’s start with the …

View Post

CAR T-Cell Therapy Is Making Untreatable Cancer Treatable

In In The News by Barbara Jacoby

By: Neel V. Patel From: dailybeast.com Immunotherapy is one of the buzziest words in medicine. Touted as the future for aggressively fighting—maybe even eliminating—diseases, the idea is to jumpstart the patient’s own immune system into better identifying and attacking diseases that normally escape attack and stealthily conquer the body. Alongside immunotherapy is the emergent ability of scientists to genetically modify …

View Post

Breakthrough cancer drug could be astronomical in price

In In The News by Barbara Jacoby

By: Liz Szabo, Kaiser Health News From: usatoday.com A new leukemia drug being hailed by doctors as a breakthrough could prove among the most expensive therapies ever on the market: For a single treatment, the price is expected to reach hundreds of thousands of dollars. “It is a revolutionary treatment,” said Dr. Prakash Satwani, a pediatric hematologist at NewYork-Presbyterian/Columbia University Medical Center, …

View Post

Novel cancer treatment wins endorsement of FDA advisers

In In The News by Barbara Jacoby

By: Laurie McGinley From: washingtonpost.com Food and Drug Administration advisers on Wednesday enthusiastically endorsed a first-of-its-kind cancer treatment that uses patients’ revved-up immune cells to fight the disease, concluding that the therapy’s benefits for desperately ill children far outweigh its potentially dangerous side effects. The unanimous recommendation from the Oncologic Drugs Advisory Committee means the treatment could be approved by the FDA …

View Post

Gene therapy to fight a blood cancer succeeds in major study

In In The News by Barbara Jacoby

By: Marilynn Marchione From: wsiltv.com An experimental gene therapy that turns a patient’s own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, its maker said Tuesday. In all, 82 percent of patients had their cancer shrink at least …